Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend

Bulletin Express

Mar 13

Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.

The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).

The company will release its audited FY2025 results and any dividend proposal following the board’s approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1150763951"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150763951\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150763951?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150763951","market":"hk","top_or_hot":-1,"title":"Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend","media":"Bulletin Express","content":"<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09996","symbol_name":"沛嘉医疗-B","start_time":0,"source_url":"","article_id":"1150763951","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150763951","pubTimestamp":1773392576,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09996":"沛嘉医疗-B"},"translate_title":"沛嘉医疗(09996)定于2026年3月25日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09996":1},"content_text":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.\nThe board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).\nThe company will release its audited FY2025 results and any dividend proposal following the board’s approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}